Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 46 of 46 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 09/17/07
End: 09/08/12
Due: 09/08/13
Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease
Phase: N/A
Priority: Normal
Start: 03/14/15
End: 10/23/19
Due: 10/23/20
Phase: N/A
Priority: Normal
Start: 04/17/20
End: 02/28/30
Due: 02/28/31
Phase: N/A
Priority: Normal
Start: 06/11/08
End: 08/20/09
Due: 08/20/10
Phase: N/A
Priority: Normal
Start: 10/23/09
End: 01/29/14
Due: 01/29/15
Phase: N/A
Priority: Normal
Start: 09/27/18
End: 02/06/21
Due: 02/06/22
Phase: N/A
Priority: Normal
Start: 07/31/06
End: 03/31/07
Due: 03/31/08
Phase: N/A
Priority: Normal
Start: 06/27/06
End: 05/08/08
Due: 05/08/09
Phase: N/A
Priority: Normal
Start: 01/02/06
End: 01/29/08
Due: 01/29/09
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 11/01/23
Due: 11/01/24
Phase: N/A
Priority: Normal
Start: 09/08/11
End: 05/28/15
Due: 05/28/16
Phase: N/A
Priority: Normal
Start: 12/18/19
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 03/09/16
End: 10/27/21
Due: 10/27/22
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 04/02/17
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 12/04/18
End: 01/15/21
Due: 01/15/22
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 06/30/32
Due: 06/30/33
Phase: N/A
Priority: Normal
Start: 02/16/24
End: 12/20/34
Due: 12/20/35
Phase: N/A
Priority: Normal
Start: 10/31/22
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 05/11/09
End: 05/01/12
Due: 05/01/13